Docosahexaenoic Acid and Bronchopulmonary Dysplasia in Preterm Infants | Zendy

Carmel T Collins | Zendy; Maria Makrides | Zendy; Andrew J. McPhee | Zendy; Thomas Sullivan | Zendy; Peter G. Davis | Zendy; Marta Thió | Zendy; Karen Simmer | Zendy; Victor Samuel Rajadurai | Zendy; Javeed Travadi | Zendy; Mary J. Berry | Zendy; Helen G. Liley | Zendy; Gillian Opie | Zendy; Kenneth Tan | Zendy; Kei Lui | Zendy; Scott A. Morris | Zendy; Jacqueline Stack | Zendy; Michael J. Stark | Zendy; M. C. Chua | Zendy; Pooja Agarwal Jayagobi | Zendy; James Holberton | Zendy; Srinivas Bolisetty | Zendy; Ian Callander | Zendy; Deborah L. Harris | Zendy; Robert A. Gibson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Docosahexaenoic Acid and Bronchopulmonary Dysplasia in Preterm Infants

Author(s) -

Carmel T Collins,

Maria Makrides,

Andrew J. McPhee,

Thomas Sullivan,

Peter G. Davis,

Marta Thió,

Karen Simmer,

Victor Samuel Rajadurai,

Javeed Travadi,

Mary J. Berry,

Helen G. Liley,

Gillian Opie,

Kenneth Tan,

Kei Lui,

Scott A. Morris,

Jacqueline Stack,

Michael J. Stark,

M. C. Chua,

Pooja Agarwal Jayagobi,

James Holberton,

Srinivas Bolisetty,

Ian Callander,

Deborah L. Harris,

Robert A. Gibson

Publication year - 2017

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1611942

Subject(s) - bronchopulmonary dysplasia , medicine , enteral administration , gestational age , retinopathy of prematurity , necrotizing enterocolitis , pediatrics , randomized controlled trial , confidence interval , relative risk , docosahexaenoic acid , birth weight , gestation , respiratory distress , parenteral nutrition , polyunsaturated fatty acid , surgery , pregnancy , fatty acid , genetics , biology , chemistry , organic chemistry

Studies in animals and in humans have suggested that docosahexaenoic acid (DHA), an n-3 long-chain polyunsaturated fatty acid, might reduce the risk of bronchopulmonary dysplasia, but appropriately designed trials are lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research